Rational design and structure–activity relationship studies reveal new esterified C20-diterpenoid alkaloid analogues active against MCF-7 human breast cancer cells
Authors:
- 7 December 2022
- journal article
- research article
- Published by Springer Nature in Journal of Natural Medicines
- Vol. 77 (2) , 276-283
Abstract
Although various diterpenoid alkaloids have been evaluated recently for antiproliferative activity against human tumor cell lines, little information is available regarding the antiproliferative effects of C20-diterpenoid alkaloids against MCF-7 cells. Six new diterpenoid alkaloid derivatives (13, 14, 22, 23, 25, 26) were prepared by C-11 and 15 esterification of kobusine (6). The natural parent alkaloid 6 and all synthesized derivatives (7 − 27, 12a, 15a, 15b, 18a, 18b) were evaluated for antiproliferative activity against MCF-7 cells. The structure-based design strategy resulted in an initial lead derivative, 11,15-dibenzoylkobusine (7; IC50 8.6 µM). Subsequent synthesized 11,15-diacylkobusine derivatives (9, 16, 20, 21, 23, 25, and 26) showed substantially increased suppressive effects against the MCF-7 cell line (IC50 2.3−4.4 µM). In contrast, parent alkaloid 6, two 11-acylkobusine derivatives (15a, 18a), and two 15-acylkobusine derivatives (15b, 18b) showed no effect. 11,15-Diacylation appears to be critical for producing antiproliferative activity in this alkaloid class and could introduce a new avenue in overcoming breast cancer cell proliferation using natural product derivatives. In a preliminary mechanism of action study, representative derivatives (5, 8, 9, and 17) decreased cyclin D1 mRNA expression. Graphical abstractKeywords
Funding Information
- Hokkaido University of Science (a Grant-in-Aid (2021))
This publication has 28 references indexed in Scilit:
- Cytotoxic esterified diterpenoid alkaloid derivatives with increased selectivity against a drug-resistant cancer cell lineBioorganic & Medicinal Chemistry Letters, 2012
- Structure–activity relationships and the cytotoxic effects of novel diterpenoid alkaloid derivatives against A549 human lung carcinoma cellsJournal of Natural Medicines, 2010
- Structure-activity relationships between the Aconitum C20-diterpenoid alkaloid derivatives and the growth suppressive activities of Non-Hodgkin’s lymphoma Raji cells and human hematopoietic stem/progenitor cellsInvestigational New Drugs, 2009
- Diterpenoid and Norditerpenoid Alkaloids from the Roots of Aconitum yesoense var. macroyesoenseHelvetica Chimica Acta, 2009
- Suppressive effects of novel derivatives prepared from Aconitum alkaloids on tumor growthInvestigational New Drugs, 2008
- Down-regulation of protein kinase Cη by antisense oligonucleotides sensitises A549 lung cancer cells to vincristine and paclitaxelCancer Letters, 2004
- Effects of Aconitum Alkaloid Kobusine and Pseudokobusine Derivatives on Cutaneous Blood Flow in Mice; II.Biological and Pharmaceutical Bulletin, 2000
- Effects of Aconitum Alkaloid Kobusine and Pseudokobusine Derivatives on Cutaneous Blood Flow in Mice.Biological and Pharmaceutical Bulletin, 1998
- Studies on Aconitum Species V. Constituents of Aconitum yesoense var. macroyesoense (Nakai) TamuraHETEROCYCLES, 1987
- Two New C20-Diterpenoid Alkaloids from Aconitum yesoense var. macroyesoense (Nakai) Tamura, Structures of Dehydrolucidusculine and N-DeethyldehydrolucidusculineHETEROCYCLES, 1985